Key result
Elevated serum urea levels (>7.5 mmol/L) at admission in older patients with hip fracture were significantly associated with higher in-hospital mortality compared to normal levels.
Why the study?
There are unmet needs for objective prognostic indicators to predict hospital mortality, inflammatory complications, and length of stay in hip fracture patients.
Does elevated serum urea at admission predict hospital mortality, inflammatory complications, and length of stay in older patients with hip fracture?
Cohort (n=1,819)
No
Does elevated serum urea at admission predict hospital mortality, inflammatory complications, and length of stay in older patients with hip fracture?
Effect estimate: OR 2.60 (95% CI 1.70-3.98)
Absolute Event Rate: 9.4% vs 3.3%
p-value: p=<0.001
In older patients with hip fracture, elevated admission serum urea is a strong, independent predictor of in-hospital mortality and postoperative inflammatory complications.
May support urea-based risk stratification in older hip fracture patients; hypothesis-generating pending prospective validation.
Background: There are unmet needs in objective prognostic indicators for Hip Fracture (HF) outcomes. Objectives: To evaluate the determinants and prognostic impact of elevated serum urea, a key factor of nitrogen homeostasis, in predicting hospital mortality, inflammatory complications and length of stay in HF patients. Methods: In 1819 patients (mean age 82.8±8.1 years; 76.4% women) with osteoporotic HF, serum urea level at admission along with 22 clinical and 35 laboratory variables were analysed and outcomes recorded. The results were validated in a cohort of 455 HF patients (age 82.1±8.0 years, 72.1% women). Results: Elevated serum urea levels (>7.5mmol/L) at admission were prevalent (44%), independently determined by chronic kidney disease, history of myocardial infarction, anaemia, hyperparathyroidism, advanced age and male gender, and significantly associated with higher mortality (9.4% vs. 3.3%, p<0.001), developing a high postoperative inflammatory response (HPIR, 22.1% vs.12.1%, p=0.009) and prolonged hospital stay (>20 days: 31.2% vs. 26.2%, p=0.021). The predictive value of urea was superior to other risk factors, most of which lost their discriminative ability when urea levels were normal. Patients with two abnormal parameters at admission, compared to subjects with the normal ones, had 3.6-5.6 -fold higher risk for hospital mortality, 2.7-7.8-fold increase in risk for HPIR and 1.3-1.7-fold higher risk for prolonged hospital stay. Patients with increased admission urea and a high inflammatory response had 9.7 times greater mortality odds compared to patients without such characteristics. Conclusion: In hip fracture patients admission serum urea is an independent and valuable predictor of hospital outcomes, in particular, mortality.
No takes yet. Share an insight, caveat, or question.
Fisher et al. (2018) conducted a cohort in Osteoporotic Hip Fracture (n=1,819). Elevated serum urea (>7.5 mmol/L) vs. Normal serum urea (≤7.5 mmol/L) was evaluated on In-hospital mortality (OR 2.60, 95% CI 1.70-3.98, p=<0.001). Elevated serum urea levels (>7.5 mmol/L) at admission in older patients with hip fracture were significantly associated with higher in-hospital mortality compared to normal levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: